To date, the functional link between the integrin-dependent signaling and the NSCLC malignancy largely comes from the αvβ6 integrin dependence of KRAS mutated adenocarcinomas (Agochiya et al., 1999; Rodriguez-Pinilla et al., 2007). Here, KRAS is linked to non-small cell lung carcinoma.